Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Steven Oberste

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
Lancet (London, England)|May 24, 2016
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trialEdwin J Asturias, Ananda S Bandyopadhyay, Steve Self, et al.
NPJ Vaccines|July 30, 2021
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine virusesRahnuma Wahid, Laina Mercer, Andrew Macadam, et al.
The Lancet. Infectious Diseases|December 21, 2019
Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort studyKevin Messacar, Emily Spence-Davizon, Christina Osborne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2016
Acute Flaccid Myelitis in the United States, August-December 2014: Results of Nationwide SurveillanceJames J Sejvar, Adriana S Lopez, Margaret M Cortese, et al.
Mbio|August 15, 2019
Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid MyelitisNischay Mishra, Terry Fei Fan Ng, Rachel L Marine, et al.
Lancet (London, England)|December 14, 2020
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trialsIlse De Coster, Isabel Leroux-Roels, Ananda S Bandyopadhyay, et al.
The Journal of Infectious Diseases|October 5, 2021
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical TrialsChristopher Gast, Ananda S Bandyopadhyay, Xavier Sáez-Llorens, et al.
Journal of the Pediatric Infectious Diseases Society|September 6, 2018
Viral Etiology of Acute Gastroenteritis in <2-Year-Old US Children in the Post-Rotavirus Vaccine EraFerdaus Hassan, Neena Kanwar, Christopher J Harrison, et al.
MMWR. Morbidity and Mortality Weekly Report|September 27, 2019
Progress Toward Poliovirus Containment Implementation - Worldwide, 2018-2019Daphne B Moffett, Anna Llewellyn, Harpal Singh, et al.
NPJ Vaccines|February 12, 2022
Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in childrenRahnuma Wahid, Laina Mercer, Chris Gast, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
Lancet (London, England)|May 24, 2016
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trialEdwin J Asturias, Ananda S Bandyopadhyay, Steve Self, et al.
NPJ Vaccines|July 30, 2021
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine virusesRahnuma Wahid, Laina Mercer, Andrew Macadam, et al.
The Lancet. Infectious Diseases|December 21, 2019
Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort studyKevin Messacar, Emily Spence-Davizon, Christina Osborne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2016
Acute Flaccid Myelitis in the United States, August-December 2014: Results of Nationwide SurveillanceJames J Sejvar, Adriana S Lopez, Margaret M Cortese, et al.
Mbio|August 15, 2019
Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid MyelitisNischay Mishra, Terry Fei Fan Ng, Rachel L Marine, et al.
Lancet (London, England)|December 14, 2020
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trialsIlse De Coster, Isabel Leroux-Roels, Ananda S Bandyopadhyay, et al.
The Journal of Infectious Diseases|October 5, 2021
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical TrialsChristopher Gast, Ananda S Bandyopadhyay, Xavier Sáez-Llorens, et al.
Journal of the Pediatric Infectious Diseases Society|September 6, 2018
Viral Etiology of Acute Gastroenteritis in <2-Year-Old US Children in the Post-Rotavirus Vaccine EraFerdaus Hassan, Neena Kanwar, Christopher J Harrison, et al.
MMWR. Morbidity and Mortality Weekly Report|September 27, 2019
Progress Toward Poliovirus Containment Implementation - Worldwide, 2018-2019Daphne B Moffett, Anna Llewellyn, Harpal Singh, et al.
NPJ Vaccines|February 12, 2022
Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in childrenRahnuma Wahid, Laina Mercer, Chris Gast, et al.
Pageof 23